Stay updated on COVID-19 Sub-Sero Study Clinical Trial
Sign up to get notified when there's something new on the COVID-19 Sub-Sero Study Clinical Trial page.

Latest updates to the COVID-19 Sub-Sero Study Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check31 days agoNo Change Detected
- Check39 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference6%
- Check46 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
- Check60 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check67 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference1.0%
- Check96 days agoChange DetectedThe drug supply status has been updated with a new withdrawal noted in December 2019, and the latest revision is v2.13.3, while the previous withdrawal from May 2021 has been removed.SummaryDifference2%
Stay in the know with updates to COVID-19 Sub-Sero Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the COVID-19 Sub-Sero Study Clinical Trial page.